The relationship between intracoronary thrombus burden and atherogenic index in patients with ST-elevation myocardial infarction

dc.contributor.authorEmlek, Nadir
dc.contributor.authorDuman, Hakan
dc.contributor.authorÖğütveren, Muhammet Mürsel
dc.contributor.authorErgül, Elif
dc.contributor.authorKoç, H.
dc.contributor.authorAydın, C.
dc.date.accessioned2023-01-10T07:07:23Z
dc.date.available2023-01-10T07:07:23Z
dc.date.issued2022
dc.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractOBJECTIVE: Increased coronary thrombus load is a strong predictor of adverse cardiovascular (CV) outcomes. Identifying predictors of intracoronary thrombus burden may contribute to the management of ST-segment elevation myocardial infarction (STEMI). We aimed at evaluating the relationship between the atherogenic index (ATI) and coronary thrombus burden in patients presenting with STEMI. PATIENTS AND METHODS: 139 patients who presented with STEMI and underwent primary percutaneous coronary intervention were included in this study. Angiographic thrombus burden was classified as previously defined in the myocardial infarction (TIMI) study group. RESULTS: The patients were divided into two groups as those with high and low thrombus load. Independent predictors of high thrombus burden were ATI (OR: 4.23, 95% CI: 2.38-7.5; p<0.001), serum creatinine level (OR: 17.4, 95% CI: 3.03-101.4; p=0.001) and non-LAD involvement (OR: 0.363, 95% CI: 0.14-0.92; p=0.034). The association of ATI with thrombus load was independent from HDL and TGL levels. CONCLUSIONS: The atherogenic index can be used as a reliable marker for increased coronary thrombus burden, which is associated with adverse CV outcomes. © 2022 Verduci Editore s.r.l. All rights reserved.
dc.identifier.citationEmlek, N., Duman, H., Ögütveren, M. M., Ergül, E., Koç, H., Durak, H., & Aydın, C. (2022). The relationship between intracoronary thrombus burden and atherogenic index in patients with ST-elevation myocardial infarction. European review for medical and pharmacological sciences, 26(19), 7229–7235. https://doi.org/10.26355/eurrev_202210_29915
dc.identifier.doi10.26355/eurrev_202210_29915
dc.identifier.endpage7235
dc.identifier.issn1128-3602
dc.identifier.issue19
dc.identifier.pmid36263533
dc.identifier.scopus2-s2.0-85140207884
dc.identifier.scopusqualityQ2
dc.identifier.startpage7229
dc.identifier.urihttps://doi.org/10.26355/eurrev_202210_29915
dc.identifier.urihttps://hdl.handle.net/11436/7378
dc.identifier.volume26
dc.identifier.wosWOS:000886100200003
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorEmlek, Nadir
dc.institutionauthorDuman, Hakan
dc.institutionauthorÖğütveren, Muhammet Mürsel
dc.language.isoen
dc.publisherVerduci Editore
dc.relation.ispartofEuropean Review for Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAtherogenic index
dc.subjectST-elevation myocardial infarction
dc.subjectThrombus burden
dc.titleThe relationship between intracoronary thrombus burden and atherogenic index in patients with ST-elevation myocardial infarction
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
eemlek-2022.pdf
Boyut:
392.66 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text / Tam Metin

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: